JP Morgan Healthcare Conference Roundup: Day One | GenomeWeb

By Edward Winnick and Tony Fong

SAN FRANCISCO (GenomeWeb News) – A busy first day of the 29th Annual JP Morgan Healthcare Conference wrapped up with several firms in the molecular tools and diagnostics industries making their pitches to investors.

Many firms talked about new markets and new products, either recently introduced or on the way, as key revenue drivers. Below are brief summaries taken from some of the firm's presentations and breakout sessions.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: Neanderthal-derived DNA linked to modern ailments, and more.

Japan needs to catch up on its gene-editing research efforts, the Japan News writes.

Hundreds of people have signed an online petition calling for zero tolerance to sexual harassment in the sciences.

Jeff Huber, former Google X senior vice president, joins Grail as its CEO.

Mar
03
Sponsored by
Agilent Technologies

This webinar will discuss the use of a hybrid capture-based FFPE DNA sequencing methodology with the potential for advancing precision oncology studies.